Company profile: Remote Diagnostic Technologies
1.1 - Company Overview
Company description
- Provider of advanced pre-hospital monitoring, cardiac therapy and data management solutions, including compact, integrated vital signs monitors and defibrillators such as Tempus ALS (Tempus Pro + Tempus LS), HeartStart Intrepid, Efficia DFM100, Tempus IC2 and Tempus Pro, plus Q-CPR measurement and feedback for improved CPR and telemedicine for remote emergencies.
Products and services
- Tempus ALS: A modular system combining the Tempus Pro monitor and Tempus LS defibrillator for prehospital monitoring and defibrillation in a unified platform
- Tempus Pro: A lightweight monitor engineered for prehospital care, offering advanced decision-making capabilities to support on-scene patient assessment
- Tempus IC2: A multi-parameter vital signs monitor with telemedicine capabilities for remote medical emergencies, enabling patient monitoring and clinician connectivity
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Remote Diagnostic Technologies
Corimmun
HQ: Germany
Website
- Description: Provider of novel therapeutics and diagnostics for heart and vascular diseases. A clinical drug development company based in Martinsried near Munich, Germany, Corimmun spans the full spectrum from research to drug development and commercialization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Corimmun company profile →
PerSys Medical
HQ: United States
Website
- Description: Provider of specialized medical and emergency products for military, law enforcement, homeland security, and EMS agencies, including the SWAT-T tourniquet, Russell Chest Seal, Celox Rapid B-CON hemostatic device, Warrior Blood & Fluid Warmer Set, Bleed Control Kit, and TruBODIES reanimated tissue training system.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PerSys Medical company profile →
Sadra Medical
HQ: United States
Website
- Description: Provider of minimally invasive alternatives to traditional surgical valve replacement, developing device-based therapies to facilitate and enhance treatment of aortic valve disease and improve patient care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sadra Medical company profile →
X-Ceptor Therapeutics
HQ: United States
Website
- Description: Provider of novel small molecule therapeutics that modulate nuclear receptors, along with a drug discovery platform for the nuclear receptor gene family, developing candidates to treat cardiovascular and metabolic disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full X-Ceptor Therapeutics company profile →
Roxwood Medical
HQ: United States
Website
- Description: Provider of advanced cardiovascular specialty catheters used in the treatment of patients with severe coronary and peripheral artery disease, offering solutions in interventional cardiology, endovascular therapy, PCI, and critical limb ischemia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Roxwood Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Remote Diagnostic Technologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Remote Diagnostic Technologies
2.2 - Growth funds investing in similar companies to Remote Diagnostic Technologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Remote Diagnostic Technologies
4.2 - Public trading comparable groups for Remote Diagnostic Technologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →